358 related articles for article (PubMed ID: 16963792)
1. Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development.
Baranczewski P; Stańczak A; Sundberg K; Svensson R; Wallin A; Jansson J; Garberg P; Postlind H
Pharmacol Rep; 2006; 58(4):453-72. PubMed ID: 16963792
[TBL] [Abstract][Full Text] [Related]
2. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery.
Yan Z; Caldwell GW
Curr Top Med Chem; 2001 Nov; 1(5):403-25. PubMed ID: 11899105
[TBL] [Abstract][Full Text] [Related]
3. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
Masimirembwa CM; Bredberg U; Andersson TB
Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
[TBL] [Abstract][Full Text] [Related]
4. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
Singh SS
Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics.
Roberts SA
Xenobiotica; 2001; 31(8-9):557-89. PubMed ID: 11569526
[TBL] [Abstract][Full Text] [Related]
6. Utility of mass spectrometry for in-vitro ADME assays.
Chu I; Nomeir AA
Curr Drug Metab; 2006 Jun; 7(5):467-77. PubMed ID: 16787156
[TBL] [Abstract][Full Text] [Related]
7. [Application and development of in vitro metabolism study at early drug discovery stage].
Wu H; Peng Y; Sun JG; Zhang XY; Zhong YX; Wang GJ
Yao Xue Xue Bao; 2013 Jul; 48(7):1071-9. PubMed ID: 24133972
[TBL] [Abstract][Full Text] [Related]
8. Drug metabolism and pharmacokinetics in drug discovery.
Roberts SA
Curr Opin Drug Discov Devel; 2003 Jan; 6(1):66-80. PubMed ID: 12613278
[TBL] [Abstract][Full Text] [Related]
9. Strategies to in vitro assessment of major human CYP enzyme activities by using liquid chromatography tandem mass spectrometry.
Lahoz A; Donato MT; Castell JV; Gómez-Lechón MJ
Curr Drug Metab; 2008 Jan; 9(1):12-9. PubMed ID: 18220567
[TBL] [Abstract][Full Text] [Related]
10. Role of drug metabolism in drug discovery and development.
Kumar GN; Surapaneni S
Med Res Rev; 2001 Sep; 21(5):397-411. PubMed ID: 11579440
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug.
Zhang H; Cui D; Wang B; Han YH; Balimane P; Yang Z; Sinz M; Rodrigues AD
Clin Pharmacokinet; 2007; 46(2):133-57. PubMed ID: 17253885
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions.
Fowler S; Zhang H
AAPS J; 2008 Jun; 10(2):410-24. PubMed ID: 18686042
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Drug Metabolism Using Liver Microsomes.
Knights KM; Stresser DM; Miners JO; Crespi CL
Curr Protoc Pharmacol; 2016 Sep; 74():7.8.1-7.8.24. PubMed ID: 27636111
[TBL] [Abstract][Full Text] [Related]
14. Prediction of pharmacokinetic drug-drug interaction caused by changes in cytochrome P450 activity using in vivo information.
Hisaka A; Ohno Y; Yamamoto T; Suzuki H
Pharmacol Ther; 2010 Feb; 125(2):230-48. PubMed ID: 19951720
[TBL] [Abstract][Full Text] [Related]
15. Computational modeling of P450s for toxicity prediction.
Mishra NK
Expert Opin Drug Metab Toxicol; 2011 Oct; 7(10):1211-31. PubMed ID: 21864218
[TBL] [Abstract][Full Text] [Related]
16. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
[TBL] [Abstract][Full Text] [Related]
17. Reaction phenotyping: advances in the experimental strategies used to characterize the contribution of drug-metabolizing enzymes.
Zientek MA; Youdim K
Drug Metab Dispos; 2015 Jan; 43(1):163-81. PubMed ID: 25297949
[TBL] [Abstract][Full Text] [Related]
18. Metabolic stability and its role in the discovery of new chemical entities.
Słoczyńska K; Gunia-Krzyżak A; Koczurkiewicz P; Wójcik-Pszczoła K; Żelaszczyk D; Popiół J; Pękala E
Acta Pharm; 2019 Sep; 69(3):345-361. PubMed ID: 31259741
[TBL] [Abstract][Full Text] [Related]
19. Prediction of pharmacokinetics and drug-drug interactions from in vitro metabolism data.
Shou M
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):66-77. PubMed ID: 15679174
[TBL] [Abstract][Full Text] [Related]
20. N-in-1 dosing pharmacokinetics in drug discovery: experience, theoretical and practical considerations.
He K; Qian M; Wong H; Bai SA; He B; Brogdon B; Grace JE; Xin B; Wu J; Ren SX; Zeng H; Deng Y; Graden DM; Olah TV; Unger SE; Luettgen JM; Knabb RM; Pinto DJ; Lam PY; Duan J; Wexler RR; Decicco CP; Christ DD; Grossman SJ
J Pharm Sci; 2008 Jul; 97(7):2568-80. PubMed ID: 17914718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
